You can learn more about BR+ NAD therapy schedules here
Nausea, vomiting, and other gastrointestinal symptoms are common, particularly when starting or increasing the dose and in T1D trials, these rates were similar to those seen in T2D and obesity trials
For others - particularly those with higher body weight or a long history of regain - a conversation with their prescriber about longer-term options, including continued use of treatments such as Mounjaro or Wegovy, is often worthwhile." GLP-1 medications are generally intended for long-term weight management rather than short-course treatment
Patients should seek urgent medical attention if they experience severe, persistent abdominal pain (which may indicate pancreatitis) or symptoms of gallbladder disease (right upper abdominal pain, fever, jaundice)
The NMR data were acquired at the National Centre for Biological Science-Tata Institute of Fundamental Research NMR Facility
This could have something to do with an increase in appetite once you stop taking weight-loss medications